1200131-07-2 Usage
Uses
Used in Pharmaceutical Industry:
4-Bromo-2,6-diethylbenzonitrile is used as a building block in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Bromo-2,6-diethylbenzonitrile is utilized as a precursor in the production of agrochemicals, helping to create compounds that can be used in pest control and crop protection.
Used in Organic Synthesis:
4-Bromo-2,6-diethylbenzonitrile is employed as a key intermediate in organic synthesis, allowing for the creation of a wide range of chemical compounds with diverse applications in various industries.
Used in Research and Development:
As a potential precursor for the synthesis of biologically active compounds, 4-Bromo-2,6-diethylbenzonitrile is used in research and development settings to explore its capabilities in creating new molecules with potential applications in medicine and other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1200131-07-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,0,1,3 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1200131-07:
(9*1)+(8*2)+(7*0)+(6*0)+(5*1)+(4*3)+(3*1)+(2*0)+(1*7)=52
52 % 10 = 2
So 1200131-07-2 is a valid CAS Registry Number.
1200131-07-2Relevant academic research and scientific papers
DIAZACARBAZOLES AND METHODS OF USE
-
Page/Page column 136, (2010/01/07)
The invention relates to 1,7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chkl) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
